Correlation Between 10X Genomics and Certara

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 10X Genomics and Certara at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 10X Genomics and Certara into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 10X Genomics and Certara, you can compare the effects of market volatilities on 10X Genomics and Certara and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 10X Genomics with a short position of Certara. Check out your portfolio center. Please also check ongoing floating volatility patterns of 10X Genomics and Certara.

Diversification Opportunities for 10X Genomics and Certara

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between 10X and Certara is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding 10X Genomics and Certara in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Certara and 10X Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 10X Genomics are associated (or correlated) with Certara. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Certara has no effect on the direction of 10X Genomics i.e., 10X Genomics and Certara go up and down completely randomly.

Pair Corralation between 10X Genomics and Certara

Considering the 90-day investment horizon 10X Genomics is expected to under-perform the Certara. In addition to that, 10X Genomics is 1.95 times more volatile than Certara. It trades about -0.17 of its total potential returns per unit of risk. Certara is currently generating about -0.15 per unit of volatility. If you would invest  1,328  in Certara on July 25, 2024 and sell it today you would lose (205.00) from holding Certara or give up 15.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

10X Genomics  vs.  Certara

 Performance 
       Timeline  
10X Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 10X Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in November 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Certara 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Certara has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in November 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

10X Genomics and Certara Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 10X Genomics and Certara

The main advantage of trading using opposite 10X Genomics and Certara positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 10X Genomics position performs unexpectedly, Certara can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Certara will offset losses from the drop in Certara's long position.
The idea behind 10X Genomics and Certara pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon